CHRO
Income statement / Annual
Last year (2023), Chromocell Therapeutics Corporation's total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, Chromocell Therapeutics Corporation's net income was -$7.38 M.
See Chromocell Therapeutics Corporation’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
| Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$199,934.00
|
| Cost of Revenue |
$2.58 M |
$391,730.00 |
$209,047.00 |
$138,585.00 |
| Gross Profit |
-$2.58 M |
-$391,730.00 |
-$209,047.00 |
$61,349.00 |
| Gross Profit Ratio |
0 |
0 |
0 |
0.31 |
| Research and Development
Expenses |
$2.58 M
|
$391,730.00
|
$209,047.00
|
$138,585.00
|
| General & Administrative
Expenses |
$4.28 M
|
$1.93 M
|
$629,949.00
|
$1.42 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$4.28 M
|
$1.93 M
|
$629,949.00
|
$1.42 M
|
| Other Expenses |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$6.86 M |
$2.32 M |
$838,996.00 |
$1.55 M |
| Cost And Expenses |
$6.86 M |
$2.32 M |
$838,996.00 |
$1.55 M |
| Interest Income |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$518,509.00 |
$140,430.00 |
$253.00 |
$1,676.00 |
| Depreciation &
Amortization |
$0.00
|
$690,452.00
|
$838,996.00
|
$1.35 M
|
| EBITDA |
-$6.86 M
|
-$1.63 M
|
$0.00
|
$0.00
|
| EBITDA Ratio |
0 |
0 |
0 |
-6.77 |
| Operating Income Ratio
|
0
|
0
|
0
|
-6.77
|
| Total Other
Income/Expenses Net |
-$518,509.00
|
-$140,430.00
|
$243,609.00
|
$693,283.00
|
| Income Before Tax |
-$7.38 M |
-$2.46 M |
-$595,387.00 |
-$660,584.00 |
| Income Before Tax Ratio
|
0
|
0
|
0
|
-3.3
|
| Income Tax Expense |
$0.00 |
-$690,452.00 |
-$838,996.00 |
-$1.35 M |
| Net Income |
-$7.38 M |
-$2.46 M |
-$595,387.00 |
-$660,584.00 |
| Net Income Ratio |
0 |
0 |
0 |
-3.3 |
| EPS |
-1.28 |
-0.43 |
-0.1 |
-0.11 |
| EPS Diluted |
-1.28 |
-0.43 |
-0.1 |
-0.11 |
| Weighted Average Shares
Out |
$5.77 M
|
$5.77 M
|
$5.77 M
|
$5.77 M
|
| Weighted Average Shares
Out Diluted |
$5.77 M
|
$5.77 M
|
$5.77 M
|
$5.77 M
|
| Link |
|
|
|
|
